← Back to Search

Mindful Garden for Delirium

N/A
Waitlist Available
Led By Steven Reynolds
Research Sponsored by Fraser Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 hours
Awards & highlights

Study Summary

This study is evaluating whether a digital therapeutic platform can reduce the use of medications for the management of delirium in critical care.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Agitation scores
Secondary outcome measures
Delirium Scores
Incidence of Unplanned Line removal
Movement Count Average
+6 more
Other outcome measures
Survey of caregivers
Survey of family members

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention armExperimental Treatment1 Intervention
Participants will receive 4 hours of exposure to the Mindful Garden digital therapeutic platform in addition to standard care
Group II: Control ArmActive Control1 Intervention
Participants will be monitored over a 4 hour period of standard care interventions
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Mindful Garden
2021
N/A
~70

Find a Location

Who is running the clinical trial?

BC Support UnitOTHER
3 Previous Clinical Trials
657 Total Patients Enrolled
Royal Columbian Hospital FoundationUNKNOWN
1 Previous Clinical Trials
30 Total Patients Enrolled
MitacsIndustry Sponsor
38 Previous Clinical Trials
4,291 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~17 spots leftby Apr 2025